European Science & Tech Business Lead

• Sep 2022 - Present

Growing the European Science & Tech business , focusing on industry sectors with innovative growth companies. For example, biotechnology, medical technology, food technology, green technology, speciality chemicals, aerospace, semiconductors and advanced manufacturing. Initial key markets are Germany, Netherlands, UK, Italy, France, Spain, and CEE. Open to opportunities: standing investments (asset/share), (re)development, sale & leaseback; JVs. Core, core+, value-add Key… Show more Growing the European Science & Tech business , focusing on industry sectors with innovative growth companies. For example, biotechnology, medical technology, food technology, green technology, speciality chemicals, aerospace, semiconductors and advanced manufacturing. Initial key markets are Germany, Netherlands, UK, Italy, France, Spain, and CEE. Open to opportunities: standing investments (asset/share), (re)development, sale & leaseback; JVs. Core, core+, value-add Key activities: ✅ Strategy development ✅ Capital raising ✅ Strategic partnerships & JVs ✅ Fund & investment management ✅ Underwriting & financing ✅ Platform & organisational development ✅ Business & brand development ✅ Thought leadership Show less Growing the European Science & Tech business , focusing on industry sectors with innovative growth companies. For example, biotechnology, medical technology, food technology, green technology, speciality chemicals, aerospace, semiconductors and advanced manufacturing. Initial key markets are Germany, Netherlands, UK, Italy, France, Spain, and CEE. Open to opportunities: standing investments (asset/share), (re)development, sale & leaseback; JVs. Core, core+, value-add Key… Show more Growing the European Science & Tech business , focusing on industry sectors with innovative growth companies. For example, biotechnology, medical technology, food technology, green technology, speciality chemicals, aerospace, semiconductors and advanced manufacturing. Initial key markets are Germany, Netherlands, UK, Italy, France, Spain, and CEE. Open to opportunities: standing investments (asset/share), (re)development, sale & leaseback; JVs. Core, core+, value-add Key activities: ✅ Strategy development ✅ Capital raising ✅ Strategic partnerships & JVs ✅ Fund & investment management ✅ Underwriting & financing ✅ Platform & organisational development ✅ Business & brand development ✅ Thought leadership Show less

Director Strategy & Operations - part of Global Strategy Group

• May 2021 - Sep 2022

Director within KPMG Strategy & Operations, part of the Global Strategy Group. Sample projects: ✅ advising the CEO/CFO & CCO of an international listed hotel group on corporate strategy development ✅ advising the CEO of a private equity held residential developer on ESG strategy development ✅ advising the global head of sustainability of an oil & gas company on net zero strategy development ✅ advising global medical technology executives on the future of work, digitalisation… Show more Director within KPMG Strategy & Operations, part of the Global Strategy Group. Sample projects: ✅ advising the CEO/CFO & CCO of an international listed hotel group on corporate strategy development ✅ advising the CEO of a private equity held residential developer on ESG strategy development ✅ advising the global head of sustainability of an oil & gas company on net zero strategy development ✅ advising global medical technology executives on the future of work, digitalisation and decarbonisation ✅ advising a global pharmaceutical company on the future of work, digitalisation and decarbonisation ✅ an M&A target assessment for a Scandinavian hotel group to feed its Benelux expansion strategy. Show less Director within KPMG Strategy & Operations, part of the Global Strategy Group. Sample projects: ✅ advising the CEO/CFO & CCO of an international listed hotel group on corporate strategy development ✅ advising the CEO of a private equity held residential developer on ESG strategy development ✅ advising the global head of sustainability of an oil & gas company on net zero strategy development ✅ advising global medical technology executives on the future of work, digitalisation… Show more Director within KPMG Strategy & Operations, part of the Global Strategy Group. Sample projects: ✅ advising the CEO/CFO & CCO of an international listed hotel group on corporate strategy development ✅ advising the CEO of a private equity held residential developer on ESG strategy development ✅ advising the global head of sustainability of an oil & gas company on net zero strategy development ✅ advising global medical technology executives on the future of work, digitalisation and decarbonisation ✅ advising a global pharmaceutical company on the future of work, digitalisation and decarbonisation ✅ an M&A target assessment for a Scandinavian hotel group to feed its Benelux expansion strategy. Show less

Head of Strategic Consulting

• Mar 2016 - Apr 2021

Sample projects: ✅ ABB Group - Technology & Robotics: global project lead role based in Zurich, leading a global team of 10 consultants (based in NL, Germany, Poland, Singapore and the US), supporting ABB with a global footprint optimization (1,500 locations) consisting of sales, production and logistics operations following a business spin-off and a cost savings program. Advising the global BU CFO's. ✅ Genmab - Biotechnology: Project lead to develop a global R&D location and… Show more Sample projects: ✅ ABB Group - Technology & Robotics: global project lead role based in Zurich, leading a global team of 10 consultants (based in NL, Germany, Poland, Singapore and the US), supporting ABB with a global footprint optimization (1,500 locations) consisting of sales, production and logistics operations following a business spin-off and a cost savings program. Advising the global BU CFO's. ✅ Genmab - Biotechnology: Project lead to develop a global R&D location and workplace strategy, resulting in a state of the art global research center at the Utrecht Bioscience Park and best-in-class BSLI-II lab. Advised the CEO, CFO and COO. ✅ ABInBev - FMCG: EMEA Portfolio Strategy Lead to assess footprint , cost optimization and capital gain opportunities across the value chain, covering breweries, warehousing, offices and depots. The geographical scope among others consisted of the UK, Netherlands, Belgium, South-Africa and Russia. ✅ Astellas Pharma - Biopharmaceutical: Global portfolio strategy covering over 300 locations in EMEA, North-America and Asia Pacific of which 80% of the footprint was located in Japan. Responsible for the identication of cost and footprint optimization thereby focusing on exit strategies, consolidation strategies, S&LB opportunities, etc. ✅ Heineken - FMCG: Global Portfolio Strategy Lead covering 34 countries. Setting up a portfolio database, formulating a case for change to centralize a CRE function. Developing country optimization plans focusing on key KPIs. ✅ IFF - Speciality Chemicals: The EMEA and APAC (real estate) integration lead for the integration with DuPont Nutrition merger: https://ir.iff.com/news-releases/news-release-details/iff-complete-merger-duponts-nutrition-biosciences-business. Responsible for footprint optimization and cost synergies assessment across the value chain with the emphasis on sales/marketing and R&D.

Associate Director - Strategic Consulting

• Feb 2012 - Mar 2016

Corporate Management Trainee

• Oct 2010 - Feb 2012

Global M&A/Divestment/IMO Consultant

• Mar 2013 - Jan 2019

Secondment role at Royal Philips, supporting the Global 🌏 M&A team with a diversity of merger, acquisition, divestment and post-merger integration projects for the Lighting and Healthcare business. Involvement in >50 global projects. M&A team member for the transformation from lighting / electronics to healthcare technology: My scope included: ✅ strategy meetings with HR, IT, R&D, Environmental, Procurement and M&A Steerco ✅ aligning the M&A and integration strategy… Show more Secondment role at Royal Philips, supporting the Global 🌏 M&A team with a diversity of merger, acquisition, divestment and post-merger integration projects for the Lighting and Healthcare business. Involvement in >50 global projects. M&A team member for the transformation from lighting / electronics to healthcare technology: My scope included: ✅ strategy meetings with HR, IT, R&D, Environmental, Procurement and M&A Steerco ✅ aligning the M&A and integration strategy with the footprint/supply chain of the NewCo ✅ location strategy development for HR, logistics, sales and manufacturing ✅ synergies analysis, integration planning (300-days) ✅ post-merger strategy implementation / program management Show less Secondment role at Royal Philips, supporting the Global 🌏 M&A team with a diversity of merger, acquisition, divestment and post-merger integration projects for the Lighting and Healthcare business. Involvement in >50 global projects. M&A team member for the transformation from lighting / electronics to healthcare technology: My scope included: ✅ strategy meetings with HR, IT, R&D, Environmental, Procurement and M&A Steerco ✅ aligning the M&A and integration strategy… Show more Secondment role at Royal Philips, supporting the Global 🌏 M&A team with a diversity of merger, acquisition, divestment and post-merger integration projects for the Lighting and Healthcare business. Involvement in >50 global projects. M&A team member for the transformation from lighting / electronics to healthcare technology: My scope included: ✅ strategy meetings with HR, IT, R&D, Environmental, Procurement and M&A Steerco ✅ aligning the M&A and integration strategy with the footprint/supply chain of the NewCo ✅ location strategy development for HR, logistics, sales and manufacturing ✅ synergies analysis, integration planning (300-days) ✅ post-merger strategy implementation / program management Show less

Global M&A & IMO Consultant

• Sep 2014 - Dec 2017

Secondment role at GSK Vaccines in Brussels & London supporting the 🌏 global acquisition and integration of Novartis Vaccines: https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/. 💊 My scope included: ✅ Business strategy meetings (R&D, Manufacturing, Commercial, HR) ✅ PMO day 1 planning, weekly updates, risk planning & mitigation ✅ Data modelling & quality optimization ✅ Integrated data modelling ✅… Show more Secondment role at GSK Vaccines in Brussels & London supporting the 🌏 global acquisition and integration of Novartis Vaccines: https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/. 💊 My scope included: ✅ Business strategy meetings (R&D, Manufacturing, Commercial, HR) ✅ PMO day 1 planning, weekly updates, risk planning & mitigation ✅ Data modelling & quality optimization ✅ Integrated data modelling ✅ Portfolio/footprint planning - aligning the global site strategies to the business strategies ✅ Day 1 implementation ✅ Value capture analysis ✅ Organisational design Show less Secondment role at GSK Vaccines in Brussels & London supporting the 🌏 global acquisition and integration of Novartis Vaccines: https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/. 💊 My scope included: ✅ Business strategy meetings (R&D, Manufacturing, Commercial, HR) ✅ PMO day 1 planning, weekly updates, risk planning & mitigation ✅ Data modelling & quality optimization ✅ Integrated data modelling ✅… Show more Secondment role at GSK Vaccines in Brussels & London supporting the 🌏 global acquisition and integration of Novartis Vaccines: https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/. 💊 My scope included: ✅ Business strategy meetings (R&D, Manufacturing, Commercial, HR) ✅ PMO day 1 planning, weekly updates, risk planning & mitigation ✅ Data modelling & quality optimization ✅ Integrated data modelling ✅ Portfolio/footprint planning - aligning the global site strategies to the business strategies ✅ Day 1 implementation ✅ Value capture analysis ✅ Organisational design Show less

Analyst

• Jul 2009 - Sep 2010

✅ Master Thesis (English) : The restructuring of CRE within (Dutch) Multinational Corporations in response to the Economic Downturn. Case studies on Shell, AkzoNobel, ING and an international recruitment company. ✅ Analyst : supporting GCS Account Directors on various international accounts such as AkzoNobel, City Bank and others. Conducting financial analysis and research on business trends & developments. ✅ Master Thesis (English) : The restructuring of CRE within (Dutch) Multinational Corporations in response to the Economic Downturn. Case studies on Shell, AkzoNobel, ING and an international recruitment company. ✅ Analyst : supporting GCS Account Directors on various international accounts such as AkzoNobel, City Bank and others. Conducting financial analysis and research on business trends & developments.

Infantry & Army Veteran

• Oct 2001 - Mar 2004

✅ Military service of 2,5 years at the Royal Dutch Army including several foreign training expeditions and a 6-month stabilization mission to Bosnia Herzegovina for the redevelopment of Bugojno and Suica (post-War) ✅ Military service of 2,5 years at the Royal Dutch Army including several foreign training expeditions and a 6-month stabilization mission to Bosnia Herzegovina for the redevelopment of Bugojno and Suica (post-War)